Literature DB >> 28355562

Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.

Michelle A Sallin1, Shunsuke Sakai1, Keith D Kauffman1, Howard A Young2, Jinfang Zhu3, Daniel L Barber4.   

Abstract

Recent data indicate that the differentiation state of Th1 cells determines their protective capacity against tuberculosis. Therefore, we examined the role of Th1-polarizing factors in the generation of protective and non-protective subsets of Mtb-specific Th1 cells. We find that IL-12/23p40 promotes Th1 cell expansion and maturation beyond the CD73+CXCR3+T-betdim stage, and T-bet prevents deviation of Th1 cells into Th17 cells. Nevertheless, IL- 12/23p40 and T-bet are also essential for the production of a prominent subset of intravascular CX3CR1+KLRG1+ Th1 cells that persists poorly and can neither migrate into the lung parenchyma nor control Mtb growth. Furthermore, T-bet suppresses development of CD69+CD103+ tissue resident phenotype effectors in lung. In contrast, Th1-cell-derived IFN-γ inhibits the accumulation of intravascular CX3CR1+KLRG1+ Th1 cells. Thus, although IL-12 and T-bet are essential host survival factors, they simultaneously oppose lung CD4 T cell responses at several levels, demonstrating the dual nature of Th1 polarization in tuberculosis. Published by Elsevier Inc.

Entities:  

Keywords:  IL-12; T cell migration; T-bet; Th1 cells; terminal effector; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28355562      PMCID: PMC5399512          DOI: 10.1016/j.celrep.2017.03.007

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  35 in total

1.  Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12.

Authors:  Shahin Shafiani; Crystal Dinh; James M Ertelt; Albanus O Moguche; Imran Siddiqui; Kate S Smigiel; Pawan Sharma; Daniel J Campbell; Sing Sing Way; Kevin B Urdahl
Journal:  Immunity       Date:  2013-06-20       Impact factor: 31.745

2.  T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate.

Authors:  Laura K Mackay; Erica Wynne-Jones; David Freestone; Daniel G Pellicci; Lisa A Mielke; Dane M Newman; Asolina Braun; Frederick Masson; Axel Kallies; Gabrielle T Belz; Francis R Carbone
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

3.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Authors:  Andrea Cruz; Alexandra G Fraga; Jeffrey J Fountain; Javier Rangel-Moreno; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Troy D Randall; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

4.  The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses.

Authors:  Jinfang Zhu; Dragana Jankovic; Andrew J Oler; Gang Wei; Suveena Sharma; Gangqing Hu; Liying Guo; Ryoji Yagi; Hidehiro Yamane; George Punkosdy; Lionel Feigenbaum; Keji Zhao; William E Paul
Journal:  Immunity       Date:  2012-10-04       Impact factor: 31.745

5.  Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells.

Authors:  Shunsuke Sakai; Keith D Kauffman; Jason M Schenkel; Cortez C McBerry; Katrin D Mayer-Barber; David Masopust; Daniel L Barber
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

6.  IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals.

Authors:  Xujian Li; K Kai McKinstry; Susan L Swain; Dyana K Dalton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

7.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; J Sypek; S Wolf; B R Bloom
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

8.  Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection.

Authors:  Danielle Freches; Hannelie Korf; Olivier Denis; Xavier Havaux; Kris Huygen; Marta Romano
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

9.  CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.

Authors:  Shunsuke Sakai; Keith D Kauffman; Michelle A Sallin; Arlene H Sharpe; Howard A Young; Vitaly V Ganusov; Daniel L Barber
Journal:  PLoS Pathog       Date:  2016-05-31       Impact factor: 6.823

10.  Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung.

Authors:  J S Woodworth; S B Cohen; A O Moguche; C R Plumlee; E M Agger; K B Urdahl; P Andersen
Journal:  Mucosal Immunol       Date:  2016-08-24       Impact factor: 7.313

View more
  40 in total

1.  The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors.

Authors:  Stella G Hoft; Michelle A Sallin; Keith D Kauffman; Shunsuke Sakai; Vitaly V Ganusov; Daniel L Barber
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Immunization with Mycobacterium tuberculosis-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in Mice.

Authors:  Claus Aagaard; Niels Peter Hell Knudsen; Iben Sohn; Angelo A Izzo; Hongmin Kim; Emma Holsey Kristiansen; Thomas Lindenstrøm; Else Marie Agger; Michael Rasmussen; Sung Jae Shin; Ida Rosenkrands; Peter Andersen; Rasmus Mortensen
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

3.  Limited Antimycobacterial Efficacy of Epitope Peptide Administration Despite Enhanced Antigen-Specific CD4 T-Cell Activation.

Authors:  Joel D Ernst; Amber Cornelius; Ludovic Desvignes; Jacqueline Tavs; Brian A Norris
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

4.  Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells.

Authors:  Michael F Goldberg; Elizabeth K Roeske; Lauren N Ward; Thomas Pengo; Thamotharampillai Dileepan; Dmitri I Kotov; Marc K Jenkins
Journal:  Immunity       Date:  2018-12-11       Impact factor: 31.745

5.  Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.

Authors:  Robyn M Jong; Erik Van Dis; Samuel B Berry; Xammy Nguyenla; Alexander Baltodano; Gabrielle Pastenkos; Chenling Xu; Douglas Fox; Nir Yosef; Sarah M McWhirter; Sarah A Stanley
Journal:  J Immunol       Date:  2021-12-29       Impact factor: 5.422

Review 6.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

Review 7.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 8.  The evolving role of T-bet in resistance to infection.

Authors:  Gretchen Harms Pritchard; Ross M Kedl; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

9.  Characterization of Mycobacterium tuberculosis-Specific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease.

Authors:  Natalie Strickland; Tracey L Müller; Natacha Berkowitz; Rene Goliath; Mary N Carrington; Robert J Wilkinson; Wendy A Burgers; Catherine Riou
Journal:  J Immunol       Date:  2017-08-09       Impact factor: 5.422

10.  Enhancement of CD4+ T Cell Function as a Strategy for Improving Antibiotic Therapy Efficacy in Tuberculosis: Does It Work?

Authors:  Diego L Costa; Eduardo P Amaral; Sivaranjani Namasivayam; Lara R Mittereder; Bruno B Andrade; Alan Sher
Journal:  Front Cell Infect Microbiol       Date:  2021-06-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.